Induction of apoptosis and altered nuclear/cytoplasmic distribution of the androgen receptor and prostate-specific antigen by 1 alpha,25-dihydroxyvitamin D-3 in androgen-responsive LNCaP cells

被引:55
作者
Hsieh, TC [1 ]
Wu, JM [1 ]
机构
[1] NEW YORK MED COLL,DEPT BIOCHEM & MOL BIOL,VALHALLA,NY 10595
关键词
D O I
10.1006/bbrc.1997.6838
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In addition to suppressing prostate cell growth, vitamin D also up-regulates the expression of androgen receptor (AR) and prostate-specific antigen (PSA). To study the mechanism involved in the control of these proteins, LNCaP cells were treated with 10 nM 1 alpha,25-dihydroxyvitamin D-3 and separated into cytosol and nuclear fractions. AR and PSA were analyzed by western blot analysis. A second approach involved incubating control and treated cells with [H-3]R1881, fractionating the cells into the cytosolic and nuclear components, and quantifying the amount of radioactivity associated with the respective fractions. Alternatively, immunohistochemical assays were performed by staining cells with cognate antibodies for AR and PSA, Both biochemical and immunohistochemical analyses show proportionately greater increased presence of AR in the nucleus, accompanied by relatively reduced AR in the cytosol, following treatment of LNCaP cells with vitamin D-3. Surprisingly, PSA was found to be present in the nuclear fraction in both control and treated cells. These results suggest that vitamin D-3 promotes the translocation of AR from the cytosol to the nucleus. The presence of PSA in the nucleus of LNCaP cells raises the possibility of an autogenous mode of control of PSA gene expression. (C) 1997 Academic Press.
引用
收藏
页码:539 / 544
页数:6
相关论文
共 32 条
[1]  
AN SJ, 1993, BIOCHEM MOL BIOL INT, V31, P279
[2]   TRANSCRIPTIONAL ACTIVATION OF HUMAN (2'-5')OLIGOADENYLATE SYNTHETASE GENE-EXPRESSION BY THE PHORBOL ESTER 12-O-TETRADECANOYL-PHORBOL 13-ACETATE IN TYPE-I-INTERFERON-TREATED HL-60 AND HELA-CELLS [J].
CHANG, CC ;
BORELLI, TJ ;
WILLIAMS, BRG ;
WU, JM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 207 (01) :297-304
[3]  
CHANG CC, 1991, J BIOL CHEM, V266, P4605
[4]   Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl)retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34(cdc2), Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells [J].
Dipietrantonio, A ;
Hsieh, TC ;
Wu, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 224 (03) :837-842
[5]  
Esquenet M, 1996, PROSTATE, V28, P182, DOI 10.1002/(SICI)1097-0045(199603)28:3<182::AID-PROS5>3.0.CO
[6]  
2-H
[7]  
Faiella L, 1996, BIOCHEM MOL BIOL INT, V39, P1085
[8]   IMMUNOCYTOCHEMICAL LOCALIZATION OF PROSTATE-SPECIFIC ANTIGEN - SPECIFICITY AND APPLICATION TO CLINICAL-PRACTICE [J].
FORD, TF ;
BUTCHER, DN ;
MASTERS, JRW ;
PARKINSON, MC .
BRITISH JOURNAL OF UROLOGY, 1985, 57 (01) :50-55
[9]   A PROSPECTIVE-STUDY OF DIETARY-FAT AND RISK OF PROSTATE-CANCER [J].
GIOVANNUCCI, E ;
RIMM, EB ;
COLDITZ, GA ;
STAMPFER, MJ ;
ASCHERIO, A ;
CHUTE, CC ;
WILLETT, WC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (19) :1571-1579
[10]   PROSTATE SPECIFIC ANTIGEN IN PATIENTS WITH CLINICAL STAGE-C PROSTATE-CANCER - RELATION TO LYMPH-NODE STATUS AND GRADE [J].
GRESKOVICH, FJ ;
JOHNSON, DE ;
TENNEY, DM ;
STEPHENSON, RA .
JOURNAL OF UROLOGY, 1991, 145 (04) :798-801